Patent details
EP2389164 Title: PHARMACEUTICAL COMPOSITIONS COMPRISING A HCV POLYMERASE INHIBITOR PRODRUG
Basic Information
- Publication number:
- EP2389164
- PCT Application Number:
- PCT/EP/2010/050182
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP107002339
- PCT Publication Number:
- WO/2010/084041
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITIONS COMPRISING A HCV POLYMERASE INHIBITOR PRODRUG
- French Title of Invention:
- COMPOSITIONS PHARMACEUTIQUES CONTENANT DES PRO-MÉDICAMENTS INHIBITEURS DE HCV POLYMÉRASE
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT EINEM HCV-POLYMERASE-INHIBITOR-PRODRUG
- SPC Number:
Dates
- Filing date:
- 11/01/2010
- Grant date:
- 13/08/2014
- EP Publication Date:
- 13/08/2014
- PCT Publication Date:
- 29/07/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 30/11/2011
- EP B1 Publication Date:
- 13/08/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 11/01/2015
- Expiration date:
- 11/01/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/01/2010
- Name:
- F. Hoffmann-La Roche AG
- Address:
- Grenzacherstraße 124, 4070 Basel, Switzerland (CH)
Inventor
1
- Name:
- CHATTERJI Ashish
- Address:
- United States (US)
2
- Name:
- DESAI Dipen
- Address:
- United States (US)
3
- Name:
- SANDHU Harpreet K.
- Address:
- United States (US)
4
- Name:
- SHAH Navnit Hargovindas
- Address:
- United States (US)
Priority
- Priority Number:
- 145999 P
- Priority Date:
- 21/01/2009
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 9/20;
| Filing date | Document type | Number of pages |
|---|